Compare BCRX & ALKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | ALKT |
|---|---|---|
| Founded | 1986 | 2007 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.9B |
| IPO Year | N/A | N/A |
| Metric | BCRX | ALKT |
|---|---|---|
| Price | $7.24 | $16.65 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $20.82 | ★ $34.57 |
| AVG Volume (30 Days) | ★ 4.2M | 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $40.21 | $35.43 |
| Revenue Next Year | $6.13 | $23.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.00 | $15.73 |
| 52 Week High | $11.31 | $33.74 |
| Indicator | BCRX | ALKT |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 34.16 |
| Support Level | $6.26 | $15.73 |
| Resistance Level | $6.91 | $16.88 |
| Average True Range (ATR) | 0.27 | 1.15 |
| MACD | 0.10 | -0.18 |
| Stochastic Oscillator | 97.13 | 13.38 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company's solution, the Alkami Digital Banking Platform, allows FIs to onboard and engage new users, accelerate revenues and meaningfully improve operational efficiency, all with the support of a proprietary, true cloud-based, multi-tenant architecture.